Stock screener

ANIP

Conviction 24HealthcareScan · Mon, Aug 10, 2026
ANIP$75.68-3.28%
ResistanceSupportVol 14Insider sell
63 bars
2
2
2
Vol MA14 436.44K
May 11May 28Jun 16Jul 6Jul 23Aug 10
ANI PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.anipharmaceuticals.com
Price75.68
Change-3.28%
Gap-2.39%
Rel volume4.77×
Avg volume395.17K
Avg $ vol31.19M
SMA 2079.49
SMA 5080.79
SMA 20080.84
Price vs 50-6.33%
Price vs 200-6.38%
MA stackbearish
50/200 cross
Supertrenddown · 85.43
RSI (14)39
MACD hist-0.19
MACD crossbear · 0d
Stoch %K / %D15 / 50
ADX (14)12
+DI / −DI16 / 23
RSI divergence
MACD divergence
ATR %+3.81%
ADR %3.04%
52w high98.81
52w low70.49
From 52w high-23.41%
Above 52w low+7.36%
New 52w highNo
SqueezeOn · 4d
Bollinger width8.44%
%B-0.07
Donchian pos15.20%
Donchian high83.21
Donchian low74.33
AVWAP (52w high)82.32
vs AVWAP high-8.07%
AVWAP (52w low)79.58
vs AVWAP low-4.91%
OBV trendDown
Chaikin MF (20)0.01
Today vs 20d4.77×
Avg vol (14d)436.44K
Avg vol (20d)395.17K
Avg $ vol (20d)31.19M
Market cap
RS 3m (vs SPY)-12.44%
RS 6m (vs SPY)-18.10%
RS line new highNo
Trend template1/8
Technical rank21.1
1 week-5.47%
1 month-7.79%
3 months-7.55%
6 months-7.53%
1 year+9.67%
YTD-3.51%
P/E24.43
P/B3.20
P/S2.17
P/FCF11.16
EPS3.32
Div yield0.06%
ROE13.12%
ROA5.24%
Debt/Eq0.50
Current2.91
EV/EBITDA11.71
Gross margin
Net margin8.87%
Rev growth43.78%
EPS growth522.94%
Price target109.00
Target upside39.12%
Analyst ratingBuy
Institutional111.02%
Ent. value1.85B
Revenue266.04M
Net income24.71M
Gross profit
Free cash flow171.39M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out22.73M
Employees970
ListedMon, Sep 13, 1999
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction24 / 100
Pattern quality
Tech rank21.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance86.31
Support77.33
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANIP

All disclosures →
No recent disclosed trades by Congress in ANIP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANIP · 6 buys · 4 sells

InsiderSideShares
CAREY STEPHEN P.
SVP & CFO · Stock Option (right to buy) · 2026-07-02
Exercise3.31K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-07-02
Sell3.31K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-07-02
Exercise3.31K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-06-29
Sell2.85K
HAUGHEY THOMAS
Director · Common Stock · 2026-06-08
Sell2K
Thoma Jeanne
Director · Common Stock · 2026-05-21
Grant4.36K
Pera Antonio R
Director · Common Stock · 2026-05-21
Grant4.36K
TANNENBAUM RENEE P
Director · Common Stock · 2026-05-21
Grant4.36K
HAUGHEY THOMAS
Director · Common Stock · 2026-05-21
Grant4.36K
Leonard Matthew J
Director · Common Stock · 2026-05-21
Grant4.36K

SEC filings

EDGAR filings in ANIP · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.